REQUEST A DEMO
Total
USD $0.00
Search more companies

EVOL-PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: EVOL-PHARMA Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

EVOL-PHARMA Kft. is an enterprise located in Hungary, with the main office in Eger. It operates in the Pharmacies and Drug Stores industry. The company was established on June 20, 2019. 22 (2024) employees currently work for EVOL-PHARMA Kft.. The latest financial highlights indicate a net sales revenue increase of 14.28% in 2024. Its total assets grew by 41.68% over the same period. In 2024, EVOL-PHARMA Kft.’s net profit margin increased by 0.57%.

Headquarters
Dobo ter 2.
Eger; Heves; Postal Code: 3300

Contact Details: Purchase the EVOL-PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the EVOL-PHARMA Kft. report to view the information.
Registered Capital:
Purchase the EVOL-PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the EVOL-PHARMA Kft. report to view the information.
Incorporation Date:
June 20, 2019
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after EVOL-PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.28%
Total operating revenue
13.4%
Operating profit (EBIT)
31.41%
EBITDA
26.51%
Net Profit (Loss) for the Period
175.15%
Total Assets
41.68%
Total Equity
10.49%
Operating Profit Margin (ROS)
0.21%
Net Profit Margin
0.57%
Return on Equity (ROE)
5.69%
Quick Ratio
-0.13%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?